Belgium· BE-AMP-SAM173065-00
Mycobutin 150 mg
A rifabutin product containing rifabutin, registered in Belgium by Pfizer. The same ATC class is registered in 15 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Rifabutin is registered in 15 of 19 countries.
Countries holding a registration under ATC J04AB04 (rifabutin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Rifabutin · ATC J04AB04
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of rifabutin costs, country by country.
Normalised to the WHO defined daily dose (0.15 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Rifabutin · price per daily dose (0.15 g)
USD · FX 28 Sept 2026
- CH Switzerland$5.51
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Rifabutin
- Manufacturer
- Pfizer
- Country
- Belgium (BE)
- ATC code
- J04AB04
- ATC class
- Rifabutin
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
1 priced- be_apb1236702EUR 231.27
- be_apb0749606
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
278 interactions on record for rifabutin.
Graded by severity as the source publishes them — 91 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rifabutin · interactions on record
278 records
- 91 severe
- 146 moderate
- 8 minor
Most severe, free to view
- RolapitantA04AD14severe
- EliglustatA16AX10severe
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
33 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Rifabutin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesRifabutinMarlex Pharmaceuticals, Inc.
- FinlandAnsatipinParanova Oy
- NorwayAnsatipinSERB
- United KingdomMycobutin 150mg capsulesPfizer Ltd
- SpainANSATIPIN 150 MG CÁPSULAS DURASBinesa 2002 S.L.
- FranceANSATIPINE 150 mg, géluleSERB
- CanadaMYCOBUTINPFIZER CANADA ULC
- IrelandMycobutin 150mg Hard CapsulesPfizer Healthcare Ireland Unlimited Company
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Mycobutin
- Czechia · Mycobutin
- Germany · Mycobutin
- Spain · Ansatipin
- Finland · Ansatipin
- France · Ansatipine
- United Kingdom (Northern Ireland) · Mycobutin, Rifabutin Pfizer
- Ireland · Mycobutin
- Italy · Mycobutin
- Luxembourg · Mycobutin
- Netherlands · Mycobutin
- Portugal · Mycobutin
- Sweden · Ansatipin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9e24c834-d581-4aa2-950a-e3f2aa2dffbc GET /v1/drugs/9e24c834-d581-4aa2-950a-e3f2aa2dffbc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Mycobutin 150 mg",
"name_fr": "Mycobutin 150 mg",
"name_nl": "Mycobutin 150 mg",
"amp_code": "SAM173065-00",
"strengths": [
"150.0000",
"12.0000"
],
"pack_count": 2,
"substances": [
"Rifabutin",
"Sodium Laurilsulfate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Rifabutin",
"authorisation_numbers": [
"BE173065"
]
}See everything about rifabutin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.